共 7 条
- [7] Secukinumab provides rapid and persistent relief in pain and fatigue symptoms in patients with ankylosing spondylitis irrespective of baseline C-reactive protein levels or prior tumour necrosis factor inhibitor therapy: 2-year data from the MEASURE 2 study CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (02) : 260 - 269